A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
A clinical trial is "blind" if participants are unaware of whether they are in the experimental or control arm of the study; also referred to as masked.
See also:
Clinical trial
Placebo
Placebo-controlled studyBaseline
Bias
Blind
Brief Summary
Baseline
Clinical Trial Enrolment
Clinical
Clinical Trial
Cohort
Control Group
Controlled Trial
Diagnostic Trials
Dichotomous Question
Dose-ranging Trial
Double blind Trial
Drop Out
Drug-drug interaction
Effectiveness
Efficacy
Eligibility Criteria
Endpoint
Experimental Drug
Informed Consent
International Clinical Trial Registry Platform (ICTRP)
Methodology
Open label Trial
Phase I Trials
Phase II Trials
Phase III Trials
Phase IV Trials
Placebo
Placebo Effect
Pre-clinical Trials
Prevention Trials
Quality of Life Trials
Randomisation
Randomised Trial
Risk-benefit analysis
Screening Trials
Single-blind Trial
Trial endpoint
Treatment Trials
Adverse Event
Adverse Reaction
Pharmacokinetics, Prophylaxis, Prior approval, Meta analysis, Fair balance, Placebo, Effectiveness, Defined daily dose (DDD), Outlier, Protocol, Recruitment status, Cardiothoracic, Experimental drug, Utility (pharmacoeconomics), European Medicines Agency,